Recordati purchases six OTC products assets
Recordati has purchased the marketing authorizations, the trademarks and additional assets related to six OTC pharmaceuticals from Cilag and McNeil in Germany.
The products include JHP-Rodler, Betadorm D, Rhinopront, Collomack Topical, Tirgon and Xitix.
Recordati chairman and CEO Giovanni Recordati said, "The OTC pharmaceutical segment in Germany is worth around EUR 4 billion and represents a share in units of 52% of the overall pharmaceutical market."
JHP-Rodler is mint oil indicated for digestive disorder, headache, cough and cold, Betadorm D isDiphenhydramine HCl indicated for sleep disorders and Rhinopront, pseudoephedrine+triprolidine, is indicated for rhinitis and head colds.
The Collomack topical, salicylic acid solution, is an anti- corn preparation, Tirgon is bisacodyl for constipation and Xitix vitamin C lozenges to treat vitamin C deficiency.
Related Insight
Suppliers Directory
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
OTC Intelligence
ICD Research's "UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" is a crucial resource for industry executives and anyone looking to access key information about "UnitedHealth Group Incorporated" ICD Research's "UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $125
Comments may be moderated for spam, obscenities or defamation.